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Abstract
Background: Mutations in the KCNJ2 gene encoding the ion channel Kir2.1 have been linked to the Andersen-Tawil
syndrome (ATS). Molecular genetic screening performed in a family exhibiting clinical ATS phenotypes unmasked a
novel sequence variant (c.434A > G, p.Y145C) in this gene. The aim of this study was to investigate the effect of this
variant on Kir2.1 ion channel functionality.
Methods: Mutant as well as wild type GFP tagged Kir2.1 channels were expressed in HEK293 cells. In order to
examine the effect of the new variant, electrophysiological measurements were performed using patch clamp
technique. Cellular localization of the mutant in comparison to the wild type ion channel was analyzed by
confocal laser scanning microscopy.
Results: The currents of cells expressing only mutant channels or a mixture of wild type and mutant were
significantly reduced compared to those expressing wild type (WT) channels (p < 0.01). Whereas WT expressing cells
exhibited at −120 mV an averaged current of −4.5 ± 1.9 nA, the mutant generates only a current of −0.17 ± 0.07 nA.
A co-expression of mutant and WT channel generates only a partial rescue of the WT current. Confocal laser scanning
microscopy indicated that the novel variant is not interfering with synthesis and/or protein trafficking.
Conclusions: The detected sequence variant causes loss-of-function of the Kir2.1 channel and explains the clinical
phenotypes observed in Andersen-Tawil syndrome patients.
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Background
The KCNJ2 gene encodes the inwardly rectifying potas-
sium channel Kir2.1 and is predominantly expressed in
excitable tissue of heart, brain and skeletal muscle [1]. In
cardiac myocytes, Kir2.1 contributes to the inwardly rec-
tifying K+ current (IK1), which is essential for stabilizing
the resting membrane potential and inducing the final
repolarization phase of the cardiac action potential [2].
Mutations in the KCNJ2 gene have been associated with
Andersen-Tawil syndrome (ATS), Short QT syndrome as
well as with Catecholaminergic polymorphic ventricular
tachycardia (CPVT) [3–5].
ATS represents a rare hereditary disorder charac-
terized by a triad of symptoms including cardiac ar-
rhythmias, periodic paralysis and dysmorphic features
[6]. However, most patients suffering from the syn-
drome do not manifest all three phenotypic features
mentioned. The clinical phenotype and also the se-
verity of the various symptoms may differ even in
members of the same family [7].
Referring to the cardiac symptoms, ATS patients suffer
from ventricular arrhythmias and may exhibit a pro-
longed QT interval in the electrocardiogram (ECG).
Therefore, ATS was also classified as long QT syndrome
and designated as subtype LQT7 [1]. However, in most
cases, the QT prolongation is marginal. Prominent U-
waves in the ECG represent an additional symptom ob-
served in affected patients [8]. Arrhythmias may induce* Correspondence: scheiper@med.uni-frankfurt.de1Institute of Legal Medicine, University Hospital Frankfurt, Goethe University,
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syncope and may eventually lead to cardiac arrest [9].
On average, cardiac abnormalities are diagnosed at an age
of 13 years and need careful cardiologic monitoring [9, 10].
Periodic paralysis and muscle weakness are another
manifestation of ATS. These symptoms are often ob-
served during early childhood and their occurrence is
highly variable. Paralysis attacks can last up to several
days [9]. Dysmorphologies associated with the disorder
include craniofacial features such as deep-set eyes, broad
forehead and nose, thin upper lip, malar, maxillary and
mandibular hypoplasia, dental anomalies as well as mild
facial asymmetries. Additionally, small hands and feet,
clinodactyly of the toes, mild syndactyly of toes two and
three, and clinodactyly of the hands are common skeletal
abnormalities observed in ATS patients [10].
The prevalence of ATS was estimated to be in the
order of 1/1,000,000 [11]. The syndrome is inherited in
an autosomal dominant fashion, but it also occurs spor-
adically [12]. About 60–70% of the patients exhibiting
clinical ATS symptoms show genetic abnormalities in
the KCNJ2 gene, mostly resulting in complete loss-of-
function [1, 13].
Molecular genetic analysis performed in a family
exhibiting clinical ATS phenotypes unmasked a se-
quence variant in the KCNJ2 gene (c.434A > G,
p.Y145C). In the present study, we investigated the




The current study was approved by the ethical commis-
sion of the University Hospital, JWG University Frankfurt
(protocol number E84/06).
Genetic analysis
Blood samples collected from individuals of the family
were utilized for genetic analysis. Targeted mutational
analysis of the ion channel gene KCNJ2 (NG_008798.1)
was performed using polymerase chain reaction (PCR)
and standard direct sequencing, starting with the index
patient. The in silico prediction tools PolyPhen-2 [14]
and MutationTaster [15] were used to assess the effect
of the detected sequence variant.
Mutagenesis
For site-directed mutagenesis, the pEGFP-N2 vector
comprising the wild type cDNA sequence of KCNJ2
was used. The required sequence variant was induced
by applying mutagenic primers in the thermal cycling
reaction using the QuikChange II XL Site-Directed
Mutagenesis Kit (Stratagene, Agilent Technologies,
Waldbronn). The resulting construct was verified by
sequencing.
Electrophysiological measurements in HEK293 cells
For the functional characterization of the variant
p.Y145C, the mutant as well as wild type Kir2.1 channels
were expressed in human embryonic kidney (HEK) cells,
cell line 293. WT and mutant were also co-transfected in
a 1/1 or 1/3 ratio (wt/mut). HEK293 cells were culti-
vated in an incubator at 37 °C, 4–5% CO2 and passaged
by transferring them to 35 mm plates. The cells were
transfected using transfection reagent TurboFect
(Thermo Fisher Scientific, Waltham, USA) and 1 μg of
Kir2.1 constructs in the EGFP-N2 vector. On the next
day, the cells were detached by means of accutase (PAA,
GE Health Freiburg, Germany). Depending on the
density of cells, 0.2, 0.3 or 0.4 ml were transferred to a
new plate containing 2 ml medium.
Electrophysiological measurements were performed on
single cells 2 days following transfection using conven-
tional patch clamp technique in whole-cell configur-
ation. Current measurements and data acquisition were
carried out with an EPC-9 Patch Clamp amplifier
(HEKA, Lambrecht, Germany) and the Patch Master
(HEKA) software. Currents were measured at room
temperature in a bath solution composed of 135 mM
NaCl, 4.8 mM KCl, 1.8 mM CaCl2, 1.8 mM MgCl2,
10 mM Glucose and 5 mM HEPES (pH 7.5). The osmo-
larity was adjusted to approximately 300 mosmol/kg.
The pipette solution consisted of 130 mM potassium
gluconate, 1 mM MgCl2, 5 mM HEPES and 2 mM ATP
which was adjusted to pH 7.4 and 250 mosmol/kg. To
monitor Kir2.1 activity, the cells were clamped from a
holding potential of −0 mV to test voltages ranging
from +60 mV to −140 mV in 20 mV steps. For data
analysis we used Igor Pro 6.03 software (WaveMetrics,
Lake Oswego, OR).
Data analysis
Results are reported as mean ± SD of n experiments.
For statistical evaluation, the Kolmogorov–Smirnov test
(KS test) was carried out to determine whether the mea-
sured data show normal distribution. Accordingly, the
student’s t-test (one-tailed) was applied to determine the
statistical significance of the results obtained.
Confocal laser scanning microscopy
HEK293 cells were cultivated on coverslips for 2 days at
37 °C, 5% CO2 and transfected with GeneJuice (Novagen,
Merck Chemicals Ltd., Hoddesdon, UK). Approximately
24 h following transfection, the fluorescence signal origin-
ating from the cells expressing the Kir2.1 channel tagged
on the c-terminus with the enhanced green fluorescent
protein (EGFP) was imaged using a Leica TCS SP5 II
Confocal Systems microscope. EGFP was excited with
an argon laser at 488 nm and emission recorded at
503–523 nm. Images were taken using a HCX PL APO
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CS 100 × 1,44 OIL UV lens and recorded under control




The index patient of the family affected by ATS (male,
III.4) exhibited clinical cardiac as well as muscular
symptoms at the age of 11 (Table 1). This patient and its
family members underwent a complete cardiologic
examination including 12-lead ECG recordings and exer-
cise stress testing. Skeletal dysmorphic features were
documented. During initial medical examination, the
index patient exhibited a serum potassium concentration
of 3.0 mmol/l (normal range: 3.5–5 mmol/l). Oral potas-
sium substitution improved symptoms within hours.
Afterwards, he and his mother got along with an appro-
priate diet as well as potassium supplements. During an-
nually follow-up checkups, their values were in the
normal range. Meanwhile the mother of the index
patient (II.2) received an implantable loop recorder, be-
cause she suffered from repeated syncope during her
work as a room attendant. No cardiac arrhythmias were
detected during syncope. As the prominent feature in
the index patient and his mother are episodes of periodic
paralysis and the dysmorphic features, we classified their
diagnosis as Andersen-Tawil syndrome. Since the pheno-
type was quite distinct, selective molecular genetic
screening of the potassium channel Kir2.1 encoding
gene KCNJ2 was performed.
Mutation analysis
In the family affected by ATS, molecular genetic screening
revealed the heterozygous point mutation c.434A > G in
exon 2 of the KCNJ2 gene leading to an amino acid substi-
tution of tyrosine to cysteine at position 145 (p.Y145C) in
the expressed ion channel protein Kir2.1. This region is
located in the selectivity filter of the channel pore (Fig. 1).
The ‘GYG’ signature sequence, which is highly conserved
among all known potassium channels, is changed into
‘GCG’. To our knowledge, this variant is not registered in
common databases (Exome Aggregation Consortium, gen-
ome Aggregation Database, NHLBI Exome Sequencing
Project, NCBI dbSNP, Human Gene Mutation Database)
and has not been functionally characterized so far. The
novel sequence variant was expected to be pathogenic ac-
cording to bioinformatics prediction tools [14, 15].
All family members carrying this sequence variant ex-
hibit characteristic phenotypes of this rare hereditary
disease. They present clinical symptoms such as U-
waves in the resting ECG, ventricular premature beats
during exercise stress test, periodic paralyses as well as
dysmorphic features including small chin, low-set ears,
hypertelorism and syndactyly (Table 1, Fig. 2).
Effect of the novel sequence variant on Kir2.1 channel
conductance
In order to examine the effect of variant p.Y145C on the
Kir2.1 channel conductance, electrophysiological mea-
surements were performed. Therefore, HEK293 cells
were transfected using the pEGFP-N2 vector comprising
either the KCNJ2 wild type cDNA sequence or the mu-
tated sequence (c.434A > G), or were co-transfected with
both constructs. By measuring the whole cell currents of
cells, which express either the WT channel or its mutant
or a mixture of both, we obtain information on the func-
tional impact of the novel sequence variant.
Cells expressing the wild type Kir2.1 channel showed
the expected features of a Kir type inward rectifier.
Clamp voltages negative of approximately −20 mV elicit
currents, which are first outward. They reverse at the K+
equilibrium voltage to produce large inward currents
with increasing negative clamp voltages. Representative
current traces as well as the mean steady state I/V
Table 1 Clinical phenotypes of the family members carrying the heterozygous mutation p.Y145C in the KCNJ2 gene
Family member Carrier Year of
birth
Cardiac symptoms Age of
onset
Muscular symptoms Age of
onset
Dysmorphic features
II. 2 Yes 1958 Syncope, Resting ECG with
U-waves, VPB during exercise
stress test starting at a heart
rate of 130 bpm
14 Mild periodic paralysis of
proximal upper limbs
55 Small chin
III. 2 No 1982 none – none – none
III. 3 Yes 1984 Resting ECG with U-waves n/a – n/a Small chin
III. 4 Yes 1990 Resting ECG with U-waves,
VPB during exercise stress
test starting at a heart rate
of 120 bpm
11 Sporadic paralysis, initially only
legs and later also arms affected
(every few weeks to months),
immediate improvement following
K- and Mg- substitution
11 Very small chin, low-set
ears, mild syndactyly
III. 5 Yes 1993 Resting ECG with U-waves n/a – n/a Small chin, hypertelorism,
mild syndactyly
bpm beats per minute, VPB ventricular premature beats, n/a not applicable
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Fig. 1 Amino acid position Y145 of the Kir2.1 channel is highly conserved in mammals. a Schematic representation of the localization of variant
Y145C in a Kir2.1 channel subunit. The detected mutation (indicated by the red dot) results in an amino acid substitution in the pore forming
region (H5). b Alignment of the Kir2.1 channel amino acid sequence among mammals. The alignment displays a partial sequence in human
(Homo sapiens), mouse (Mus musculus), dog (Canis lupus familiaris), pig (Sus scrofa) and cattle (Bos taurus)
Fig. 2 The mutant p.Y145C was detected in a family with diagnosed ATS. a Pedigree of the family. Filled symbols indicate clinically affected
individuals. +/− represents heterozygous carriers of mutation Y145C in KCNJ2 and −/− indicates exclusion of Y145C. Crossed symbols represent
deceased family members. b ATS index patient (arrow in a) exhibiting typical clinical symptoms such as small chin, low-set ears and hypertelorism
(not shown) c Prominent U-waves in resting ECG (scale 50 mm/s) of the ATS patient. Reprinted with permission from Beckmann and Kääb as well
as the Hans Marseille Verlag [21]
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relation from 5 cells are shown in Fig. 3. In contrast to
cells expressing the WT channel, mutant transfected
cells exhibit almost no current. Even at negative poten-
tials, the currents in these cells are minute and reveal no
apparent inward rectification (Fig. 3).
To simulate the allelic heterozygosity, HEK293 cells
were co-transfected with WT and Y145C mutant chan-
nel (wt/mut) at a 1/1 or 1/3 ratio with a total of 1 μg
DNA per dish. Representative currents and the mean
current/voltage relations from measurements in co-
transfected cells are shown in Fig. 3 a, b. The latter cur-
rents and I/V relations are different from those recorded
in cells with either WT channel or mutant channel only.
The currents at −120 mV generated by co-expression
(1/1: −1.5 ± 1.8 nA (n = 11); 1/3: −0.6 ± 0.6 nA (n = 9))
are significantly smaller than currents produced by the
WT channel (−4.5 ± 1.9 nA (n = 5)). Unlike the cur-
rents measured in cells expressing the mutant channel
only (−0.17 ± 0.07 nA (n = 8)) a co-expression of WT
and mutant causes a small but Kir2.1 typical inward
rectifying current. The results of these experiments
imply that the pore mutation has a dominant negative
effect on the Kir2.1 function. A co-expression with WT
channels, which mimics allelic heterozygosity, generates
a small Kir2.1 current meaning that a co-expression is
not able to rescue WT channel activity. At moderate
membrane voltage, e.g. voltages which are relevant for
the free running voltage, the Kir2.1 mediated outward
current is about 5-fold lower (Fig. 3b) than that pro-
duced by the WT channel.
Cellular localization of Kir2.1 WT and p.Y145C mutant
channels
The electrophysiological measurements indicated that
the expression of mutant Kir2.1 channels in HEK293
cells results in impaired conductivity. In order to investi-
gate, whether the sequence variant interferes with pro-
tein trafficking, confocal laser scanning microscopy was
performed. HEK293 cells were transfected with either
WT or mutant GFP tagged Kir2.1 channels and analyzed
for the cellular localization of the channel protein.
Figure 4 shows the fluorescence signal of EGFP in exem-
plary cells, which express either the WT or the mutant
channel. The cellular distribution of the fluorescence is
indistinguishable between both cells. Both exhibit a cen-
tral fluorescent structure, which presumably reflects the
Golgi apparatus; the latter is generally visible in cells,
which overexpress a protein. More important for the
present data is that the green fluorescence is localized at
the cell membrane in both cases; the membrane
localization is well visible in the filopodia of the cells,



















Fig. 3 Representative currents and current/voltage relations recorded from HEK293 cells expressing different Kir2.1 constructs. a Current traces of
HEK293 cells expressing WT Kir2.1 channels or the Y145C mutant alone. WT and mutant were also co-transfected in a 1/1 or 1/3 ratio (wt/mut).
b Mean current/voltage relations (± standard deviation) from measurements as in a from HEK293 cells expressing WT (●), mutant (○) or a 1:1 (▲)
or 1:3 mixture (△) of WT and mutant channels. The mean value of the WT current at −120 mV is significantly higher (p < 0.01, **) than any of the
other constructs. At −120 mV, co-expression of WT and mutant generates an inward current, which is significantly higher (p < 0.05; *) than those
measured with the mutant channel only
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results indicate that the WT and the mutant channel
show no appreciable difference in trafficking of the
channel protein to the plasma membrane on this level of
resolution.
Discussion
Mutations in the KCNJ2 gene have been reported to cause
Andersen-Tawil syndrome [3, 4, 16]. About 60–70% of the
patients exhibiting clinical ATS symptoms show abnor-
malities in this gene [1, 13].
Here we report a novel KCNJ2 sequence variant
(p.Y145C) in a family with diagnosed ATS. All family
members screened and presenting clinical phenotypes of
this rare hereditary disease are heterozygous carriers of
the new variant. The fact that the family member, who is
not carrying the missense variant, is not exhibiting any
ATS symptoms suggests that the new variant localized
in the channel pore of the Kir2.1 channel contributes to
the symptoms in ATS patients.
All registered mutations localized in the pore forming
region of the Kir2.1 channel and adjacent to variant
p.Y145C have been classified as pathogenic. The
p.Y145C variant is localized in the signature sequence of
K+ channels, which forms the selectivity filter of these
channels and which is essential for proper channel func-
tion. Mutations in this domain, namely at amino acid
positions 144 and 146 in the Kir2.1 channel, have
already been declared as ‘hotspots’ referring to the
Andersen-Tawil syndrome [9]. Based on these facts, it
was already assumed that the new sequence variant,
which we report here, corrupts ion channel function and
constitutes to the Andersen-Tawil phenotypes of the pa-
tients carrying this sequence aberration.
Functional analysis of cells expressing WT and mutant
Kir2.1 channel confirms that the mutant Kir2.1 channel
is indeed functionally impaired. In contrast to the large
inward currents detected in cells expressing the wild
type channel, the mutant channels generated no
appreciable inwardly rectifying current. Also in co-
expression experiments, the pore mutation showed a
dominant negative effect on ion channel function. The
current response of cells expressing only the mutant
channel was just slightly higher than the current re-
sponse observed in non-transfected cells. This con-
ductance is not voltage dependent and hence not
caused by Kir2.1 activity. It is more likely an unspecific
side effect of an overexpression of channel protein. Up
to now, all KCNJ2 mutations, which were functionally
characterized and associated with the Andersen-Tawil
syndrome, resulted in complete loss-of-function when
expressed as homotetramers [16]. The amino acid sub-
stitution of tyrosine by cysteine in the selectivity filter
corrupts the delicate structure for ion permeation
rendering the channel nonfunctional. The same non-
functional Kir2.1 channels were already reported as a
consequence of mutations in close vicinity to the
p.Y145C variant [9]. Co-expression experiments of ad-
jacent variants also showed a dominant negative im-
pact on channel function [1]. Dart et al. [17] obtained
similar results when they expressed the mutant Y145C
in the murine potassium channel Kir2.1 in Chinese ham-
ster ovary (CHO) cells to determine the characteristics of
the pore lining residues.
Aberrant ion channel functionality is not always based
on conduction defects. Bendahhou et al. [18] showed
that sequence aberrations in Kir2.1 channels may also
result in impaired channel trafficking to the cell surface.
Taking this into account, the patch-clamp experiments
can be interpreted in two ways, namely, in that the mu-
tation renders the channel inactive or that it impairs
synthesis and/or trafficking of the protein to the plasma
membrane. Given the fact that the mutation is localized
right in the most conserved domain of K+ channels and
that nearly all mutations in this domain impair channel
function [19], it is most likely to assume that the Y145C
mutant is inactive. To examine this hypothesis, we
Fig. 4 Cellular localization of GFP tagged wild type and mutant Kir2.1 channels expressed in HEK293 cells. a EGFP fluorescence signal of a cell
expressing Kir2.1 wild type. b EGFP fluorescence signal of a cell expressing Kir2.1 mutant p.Y145C. Both images were taken in the equatorial plane
of cells using confocal laser scanning microscopy
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subsequently tested whether the sequence variant in-
terferes with protein trafficking by confocal laser scan-
ning microscopy using GFP tagged channel proteins.
The analysis of the confocal images shows no obvious
differences between the WT and mutant channel pro-
teins. Both exhibit a similar fluorescence at the plasma
membrane indicating that the new variant Y145C is
not interfering with protein trafficking. This again sup-
ports the assumption that the new variant impairs
Kir2.1 channel conductance and hence reduced in-
wardly rectifying (IK1) currents.
Referring to the clinical ATS phenotypes in the af-
fected family, all Y145C carriers exhibited a resting ECG
with prominent U-waves. This can be explained by a re-
duction of IK1 currents due to mutant Kir2.1 channel ex-
pression [9]. Defects in Kir2.1 channels have also been
shown to trigger an increased frequency of spontaneous
action potentials [10]. This could explain the occurrence
of ventricular premature beats in case of two ATS pa-
tients. Moreover, a reduced IK1 current in skeletal
muscle tissues may result in an imbalance of potassium
ions and reduced membrane excitability leading to
muscle weakness and periodic paralysis [9]. These symp-
toms have been linked to ATS and were also observed in
the ATS patients carrying the Kir2.1 channel variant
Y145C. In our patients oral potassium supplementation
resulted in resolution of paralysis within hours. As the
patients do not suffer from serious cardiac symptoms
showing few ventricular premature beats only until now,
the current risk to develop a tachycardiomyopathy or a
life threatening arrhythmia is considered to be low and
cardiological examinations including echocardiographic
screening is performed on a regular basis with reassess-
ment of the risk. Therefore, no specific therapy has been
initiated next to potassium supplementation until now.
In the case of patient II.2, which represents the mother
of the index patient, an implantable loop recorder has
been implanted meanwhile due to the occurrence of pre-
syncopes and syncopes and again she suffered from re-
peated syncope. However, during syncope no cardiac
arrhythmias were documented. Recently, Tully et al. [20]
described the detection of the novel variant in a family
with diagnosed ATS and concluded that the disease is
likely caused by the variation. Our results verify the
authors’ assumption that this variant results in clinical
ATS phenotypes.
Conclusion
A novel sequence variant (p.Y145C) localized in the
highly conserved pore forming region of the potassium
channel Kir2.1 was identified. This variant was detected
in a family exhibiting phenotypes of Andersen-Tawil syn-
drome. Functional characterization of this variant indi-
cated that the mutation results in loss-of-function of the
Kir2.1 channel. The channel mutant generated no appre-
ciable current when expressed as homotetramer in
HEK293 cells. This lack of conductance must be caused
by a corruption of channel function as a result of the
mutation in the selectivity filter. A co-expression of the
WT channel with the mutant, a condition, which simu-
lates the heterozygous condition, causes a strong reduc-
tion of the channel current suggesting a strong dominant
negative effect of the pore mutation on Kir2.1 function in
a channel tetramer. Trafficking of the mutant to the
plasma membrane appears largely unaffected; confocal
images of GFP tagged channel proteins revealed no dif-
ferences between WT and mutant Kir2.1 proteins. The
results suggest that mutant Y145C in the Kir2.1 chan-
nel can be associated with the clinical phenotypes of
the Andersen-Tawil syndrome patients. These findings
may help to improve future genetic counselling and
medical treatment of patients carrying this variant.
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